Yingdong Lu
Impact in
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Gut microbiota and health 2
- TGF-β signaling in diseases 2
-
- Cardiac Fibrosis and Remodeling 3
- Co-authors
- Xiangning Cui (15 shared papers)Mi Xiang (8 shared papers)Chang Shang (7 shared papers)Laiyun Xin (7 shared papers)Yuling Wang (4 shared papers)Hongchen Lin (5 shared papers)Zihuan Shen (7 shared papers)Yi Qu (4 shared papers)
- Journals
- Frontiers in Cardiovascular Medicine (3 papers)Biomedicine & Pharmacotherapy (3 papers)Frontiers in Pharmacology (3 papers)International Journal of Cardiology (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Yingdong Lu
27 papers receiving 922 citations
Yingdong Lu's Hit Papers
Peers
Comparison fields: 5 of 93
- Complementary and alternative medicine 65
- Business and International Management 16
- Cancer Research 97
- Cardiology and Cardiovascular Medicine 134
- Molecular Biology 413
Countries citing papers authored by Yingdong Lu
This map shows the geographic impact of Yingdong Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingdong Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingdong Lu more than expected).
Fields of papers citing papers by Yingdong Lu
This network shows the impact of papers produced by Yingdong Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingdong Lu. The network helps show where Yingdong Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingdong Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments Hit paper breakdown → | 2021 | 206 |
| 2 | 2021 | 126 | |
| 3 | 2014 | 80 | |
| 4 | 2021 | 69 | |
| 5 | 2020 | 65 | |
| 6 | The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms Hit paper breakdown → | 2024 | 59 |
| 7 | 2022 | 59 | |
| 8 | 2018 | 55 | |
| 9 | 2022 | 45 | |
| 10 | 2022 | 21 | |
| 11 | 2015 | 19 | |
| 12 | Qiliqiangxin prevents right ventricular remodeling by inhibiting apoptosis and improving metabolism reprogramming with pulmonary arterial hypertension. | 2020 | 19 |
| 13 | 2014 | 18 | |
| 14 | 2022 | 16 | |
| 15 | 2013 | 16 | |
| 16 | 2018 | 15 | |
| 17 | 2015 | 11 | |
| 18 | 2020 | 8 | |
| 19 | 2020 | 6 | |
| 20 | 2024 | 6 |
About Yingdong Lu
Yingdong Lu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 29 papers that have together received 935 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Ferroptosis and cancer prognosis (2 papers), Gut microbiota and health (2 papers), Traditional Chinese Medicine Analysis (2 papers), TGF-β signaling in diseases (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Complementary and alternative medicine (65 citations), Business and International Management (16 citations), Cancer Research (97 citations), Cardiology and Cardiovascular Medicine (134 citations) and Molecular Biology (413 citations). Yingdong Lu has collaborated with scholars based in China and United States. Frequent co-authors include Xiangning Cui, Mi Xiang, Chang Shang, Laiyun Xin, Yuling Wang, Hongchen Lin, Zihuan Shen, Yi Qu, Jialiang Gao and Mingjing Zhao. Their work appears in journals such as Frontiers in Cardiovascular Medicine, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, International Journal of Cardiology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.